TY - JOUR A1 - Heidler, Juliana A1 - Fysikopoulos, Athanasios A1 - Wempe, Frank A1 - Seimetz, Michael A1 - Bangsow, Thorsten A1 - Tomasovic, Ana A1 - Veit, Florian A1 - Scheibe, Susan A1 - Pichl, Alexandra A1 - Weisel, Friederike A1 - Lloyd, K. C. Kent A1 - Jaksch, Peter A1 - Klepetko, Walter A1 - Weißmann, Norbert A1 - Melchner, Harald von T1 - Sestrin-2, a repressor of PDGFRβ signalling, promotes cigarette-smoke-induced pulmonary emphysema in mice and is upregulated in individuals with COPD T2 - Disease models & mechanisms N2 - Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. COPD is caused by chronic exposure to cigarette smoke and/or other environmental pollutants that are believed to induce reactive oxygen species (ROS) that gradually disrupt signalling pathways responsible for maintaining lung integrity. Here we identify the antioxidant protein sestrin-2 (SESN2) as a repressor of PDGFRβ signalling, and PDGFRβ signalling as an upstream regulator of alveolar maintenance programmes. In mice, the mutational inactivation of Sesn2 prevents the development of cigarette-smoke-induced pulmonary emphysema by upregulating PDGFRβ expression via a selective accumulation of intracellular superoxide anions (O2−). We also show that SESN2 is overexpressed and PDGFRβ downregulated in the emphysematous lungs of individuals with COPD and to a lesser extent in human lungs of habitual smokers without COPD, implicating a negative SESN2-PDGFRβ interrelationship in the pathogenesis of COPD. Taken together, our results imply that SESN2 could serve as both a biomarker and as a drug target in the clinical management of COPD. KW - COPD KW - KGF KW - PDGFRβ KW - ROS KW - Sestrin 2 Y1 - 2013 UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/34219 UR - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-342195 SN - 1754-8403 SN - 1754-8411 N1 - Copyright © 2013. Published by The Company of Biologists Ltd This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. VL - 6 IS - 6 SP - 1378 EP - 1387 PB - Company of Biologists Limited CY - Cambridge ER -